AAUM (Average Assets Under Management) of ₹299.44 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.7% | 66.1% | ▲ +0.5% |
| Healthcare Services | 28.3% | 28.4% | ● +0.1% |
| Insurance | 2.5% | 1.0% | ▼ -1.5% |
| N.A. | 0.0% | 1.0% | ▲ +1.0% |
| IT - Services | 0.3% | 0.0% | ▼ -0.3% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.1% | 69.1% | ▲ +3.0% |
| Healthcare Services | 28.4% | 25.0% | ▼ -3.3% |
| N.A. | 1.0% | 1.0% | ● 0.0% |
| Insurance | 1.0% | 0.9% | ▼ -0.1% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Weight (Aug 2026) |
|---|---|---|---|
| 1 | Gland Pharma Limited ₹10.10 Cr |
Pharmaceuticals & Biotechnology | 3.05% |
| 2 | Jubilant Pharmova Limited ₹4.85 Cr |
Pharmaceuticals & Biotechnology | 1.46% |
| 3 | AstraZeneca Pharma India Limited ₹4.17 Cr |
Pharmaceuticals & Biotechnology | 1.26% |
| # | Stock | Sector | Last Weight (Jul 2026) |
|---|---|---|---|
| 1 | Abbott India Limited ₹6.95 Cr |
Pharmaceuticals & Biotechnology | 2.18% |
| 2 | Concord Biotech Limited ₹1.42 Cr |
Pharmaceuticals & Biotechnology | 0.44% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹19.28 Cr |
Healthcare Services | 3.44% | 5.81% | +2.37% |
| 2 | Lupin Limited ₹13.13 Cr |
Pharmaceuticals & Biotechnology | 1.70% | 3.96% | +2.26% |
| 3 | Shilpa Medicare Ltd ₹12.34 Cr |
Pharmaceuticals & Biotechnology | 2.49% | 3.72% | +1.23% |
| 4 | GlaxoSmithKline Pharmaceuticals Limited ₹12.20 Cr |
Pharmaceuticals & Biotechnology | 2.49% | 3.68% | +1.19% |
| 5 | Narayana Hrudayalaya Limited ₹8.58 Cr |
Healthcare Services | 1.59% | 2.59% | +1.00% |
| 6 | Syngene International Limited ₹8.02 Cr |
Healthcare Services | 1.93% | 2.42% | +0.49% |
| 7 | Eris Lifesciences Limited ₹7.78 Cr |
Pharmaceuticals & Biotechnology | 1.92% | 2.35% | +0.43% |
| 8 | Divi's Laboratories Limited ₹14.20 Cr |
Pharmaceuticals & Biotechnology | 4.04% | 4.28% | +0.24% |
| 9 | Alivus Life Sciences ₹4.52 Cr |
Pharmaceuticals & Biotechnology | 1.17% | 1.36% | +0.19% |
| 10 | Aurobindo Pharma Limited ₹13.74 Cr |
Pharmaceuticals & Biotechnology | 3.96% | 4.14% | +0.18% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Apollo Hospitals Enterprise Limited ₹18.69 Cr |
Healthcare Services | 8.41% | 5.64% | -2.77% |
| 2 | Dr. Lal Path Labs Limited ₹2.90 Cr |
Healthcare Services | 3.46% | 0.88% | -2.58% |
| 3 | Glenmark Pharmaceuticals Limited ₹7.44 Cr |
Pharmaceuticals & Biotechnology | 3.50% | 2.24% | -1.26% |
| 4 | Ajanta Pharma Limited ₹5.76 Cr |
Pharmaceuticals & Biotechnology | 2.93% | 1.74% | -1.19% |
| 5 | Global Health Limited ₹8.14 Cr |
Healthcare Services | 3.61% | 2.45% | -1.16% |
| 6 | Torrent Pharmaceuticals Limited ₹11.15 Cr |
Pharmaceuticals & Biotechnology | 4.50% | 3.36% | -1.14% |
| 7 | Orchid Pharma Limited ₹3.59 Cr |
Pharmaceuticals & Biotechnology | 1.70% | 1.08% | -0.62% |
| 8 | Cipla Limited ₹21.14 Cr |
Pharmaceuticals & Biotechnology | 6.92% | 6.38% | -0.54% |
| 9 | Healthcare Global Enterprises Limited ₹5.50 Cr |
Healthcare Services | 2.10% | 1.66% | -0.44% |
| 10 | Sun Pharmaceutical Industries Limited ₹34.73 Cr |
Pharmaceuticals & Biotechnology | 10.91% | 10.48% | -0.43% |
35 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹34.73 Cr |
Pharmaceuticals & Biotechnology |
10.48%
|
|
| 2 |
₹21.14 Cr |
Pharmaceuticals & Biotechnology |
6.38%
|
|
| 3 |
₹19.28 Cr |
Healthcare Services |
5.81%
|
|
| 4 |
₹18.69 Cr |
Healthcare Services |
5.64%
|
|
| 5 |
₹14.20 Cr |
Pharmaceuticals & Biotechnology |
4.28%
|
|
| 6 |
₹13.74 Cr |
Pharmaceuticals & Biotechnology |
4.14%
|
|
| 7 |
₹13.13 Cr |
Pharmaceuticals & Biotechnology |
3.96%
|
|
| 8 |
₹12.34 Cr |
Pharmaceuticals & Biotechnology |
3.72%
|
|
| 9 |
₹12.20 Cr |
Pharmaceuticals & Biotechnology |
3.68%
|
|
| 10 |
₹11.54 Cr |
Pharmaceuticals & Biotechnology |
3.48%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.